Related references
Note: Only part of the references are listed.The Effect of Competing Direct-to-Consumer Advertising Campaigns on the Use of Drugs for Benign Prostatic Hyperplasia: Time Series Analysis
Sean C. Skeldon et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2015)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries
Z. Wang et al.
OSTEOPOROSIS INTERNATIONAL (2014)
CHRISTMAS 2014: MEDIA STUDIES Televised medical talk shows-what they recommend and the evidence to support their recommendations: a prospective observational study
Christina Korownyk et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
Michael McClung et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012
Diane K. Wysowski et al.
BONE (2013)
Trends in hip fracture rates in Canada: An age-period-cohort analysis
Sonia Jean et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Bisphosphonates for Osteoporosis - Where Do We Go from Here?
Marcea Whitaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long?
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bisphosphonate Use for ≥5 Years Increased Risk for Subtrochanteric or Femoral Shaft Fractures
Joseph M. Lane
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2011)
Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007
Zhong Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
Jorg Schilcher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
Alex Fisher et al.
CLINICAL INTERVENTIONS IN AGING (2010)
Trends and determinants of prescription medication use for treatment of osteoporosis
Joel F. Farley et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Incidence and Mortality of Hip Fractures in the United States
Carmen A. Brauer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Trends in Hip Fracture Rates in Canada
William D. Leslie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Reports of Esophageal Cancer with Oral Bisphosphonate Use
Diane K. Wysowski
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Use of alendronate and risk of incident atrial fibrillation in women
Susan R. Heckbert et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Trust and sources of health information - The impact of the Internet and its implications for health care providers: Findings from the first Health Information National Trends Survey
BW Hesse et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
SL Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
Coverage by the news media of the benefits and risks of medications
R Moynihan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
